Market Access News | pharmaphorum

News

Innovent has filed a new high-strength version of its weight-loss drug mazdutide in China, aiming to help people with severe obesity.

News

A new FDA approval means Novartis now has a gene therapy option for almost everyone with spinal muscular atrophy (SMA), regardless of their age.

News

Waltz Health is planning to disrupt the weight-loss therapy market in the US with a new direct-to-employer sales channel.

News

Patients with ATTR-CM in England and Wales will soon have a new treatment option, after NICE backed use of Alnylam's three-month injectable Amvuttra.

News

Five AI technologies used during a colonoscopy exam to help detect the early signs of bowel cancer have been backed for use by the NHS in England.

News

Bayer joins Boehringer with FDA approval for a second-line, oral therapy for HER2-positive lung cancer, setting up a marketing battle in the US.